, Tedros said several vaccines are currently being developed that could deal with the Sudan strain. Two of those vaccines “could be put in clinical trial in Uganda in the coming weeks pending regulatory and other approvals from the Ugandan government,” he said.
“Our primary focus now is to rapidly control and contain this outbreak to protect neighbouring districts as well as neighbouring countries,” explain Tedros. Tedros did not give details of the vaccines due for trial including their names or which firms developed them. Ebola, a hemorrhagic fever, mainly spreads through contact with the bodily fluids of an infected person.
Symptoms of the viral disease include intense weakness, muscle pain, headaches and a sore throat, vomiting, diarrhoea and rashes among others. Although it has no vaccine, WHO has previously said the Sudan strain is less transmissible and has shown a lower fatality rate in previous outbreaks than Ebola Zaire.